BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Omokawa M, Ayabe T, Nagai T, Imanishi A, Omokawa A, Nishino S, Sagawa Y, Shimizu T, Kanbayashi T. Decline of CSF orexin (hypocretin) levels in Prader-Willi syndrome. Am J Med Genet 2016;170:1181-6. [DOI: 10.1002/ajmg.a.37542] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Saad AK, Akour A, Mahboob A, Aburuz S, Sadek B. Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities. Pharmaceuticals 2022;15:612. [DOI: 10.3390/ph15050612] [Reference Citation Analysis]
2 Malter M, Neuneier J, Triller A, Kallweit U. [Narcolepsy in adults: Definition, etiology and treatment]. Fortschr Neurol Psychiatr 2021;89:103-13. [PMID: 33339064 DOI: 10.1055/a-1244-2612] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Salles J, Lacassagne E, Benvegnu G, Berthoumieu SÇ, Franchitto N, Tauber M. The RDoC approach for translational psychiatry: Could a genetic disorder with psychiatric symptoms help fill the matrix? the example of Prader-Willi syndrome. Transl Psychiatry 2020;10:274. [PMID: 32772048 DOI: 10.1038/s41398-020-00964-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Gillett ES, Perez IA. Disorders of Sleep and Ventilatory Control in Prader-Willi Syndrome. Diseases 2016;4:E23. [PMID: 28933403 DOI: 10.3390/diseases4030023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
5 Kabasakalian A, Ferretti CJ, Hollander E. Oxytocin and Prader-Willi Syndrome. Curr Top Behav Neurosci 2018;35:529-57. [PMID: 28956320 DOI: 10.1007/7854_2017_28] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Mendiola AJP, LaSalle JM. Epigenetics in Prader-Willi Syndrome. Front Genet 2021;12:624581. [PMID: 33659026 DOI: 10.3389/fgene.2021.624581] [Reference Citation Analysis]
7 Dunietz GL, Vanini G, Shannon C, O'Brien LM, Chervin RD. Associations of plasma hypocretin-1 with metabolic and reproductive health: Two systematic reviews of clinical studies. Sleep Med Rev 2020;52:101307. [PMID: 32259696 DOI: 10.1016/j.smrv.2020.101307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Cataldi M, Arnaldi D, Tucci V, De Carli F, Patti G, Napoli F, Pace M, Maghnie M, Nobili L. Sleep disorders in Prader-Willi syndrome, evidence from animal models and humans. Sleep Med Rev 2021;57:101432. [PMID: 33567377 DOI: 10.1016/j.smrv.2021.101432] [Reference Citation Analysis]
9 Ono H, Kanbayashi T, Imanishi A, Ayabe T, Sagawa Y, Tsutsui K, Ohmori Y, Takeshima M, Nishino S, Shimizu T. Clinical characteristics of symptomatic narcolepsy or hypersomnia: an analysis of 182 consecutive cases with neurological disorders associated with hypersomnolence. Sleep Biol Rhythms 2019;17:123-40. [DOI: 10.1007/s41105-018-0186-2] [Reference Citation Analysis]
10 Mohammadi S, Dolatshahi M, Zare-shahabadi A, Rahmani F. Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options. Brain Research 2019;1718:212-22. [DOI: 10.1016/j.brainres.2019.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Pugliese G, Barrea L, Sanduzzi Zamparelli A, de Alteriis G, Laudisio D, Muscogiuri G, Canora A, Bocchino M, Colao A, Savastano S. Body composition and obstructive sleep apnoea assessment in adult patients with Prader-Willi syndrome: a case control study. J Endocrinol Invest 2022. [PMID: 35723851 DOI: 10.1007/s40618-022-01831-5] [Reference Citation Analysis]
12 Chelimsky G, Chelimsky T. Unusual Structural Autonomic Disorders Presenting in Pediatrics. Pediatric Clinics of North America 2017;64:173-83. [DOI: 10.1016/j.pcl.2016.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
13 Govorunova EG, Koppel LA. The Road to Optogenetics: Microbial Rhodopsins. Biochemistry (Mosc) 2016;81:928-40. [PMID: 27682165 DOI: 10.1134/S0006297916090029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
14 Pace M, Falappa M, Freschi A, Balzani E, Berteotti C, Lo Martire V, Kaveh F, Hovig E, Zoccoli G, Amici R, Cerri M, Urbanucci A, Tucci V. Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors. JCI Insight 2020;5:137495. [PMID: 32365348 DOI: 10.1172/jci.insight.137495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
15 Tan HL, Urquhart DS. Respiratory Complications in Children with Prader Willi Syndrome. Paediatr Respir Rev 2017;22:52-9. [PMID: 27839656 DOI: 10.1016/j.prrv.2016.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
16 Berteotti C, Liguori C, Pace M. Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders. Eur J Neurosci 2021;53:1136-54. [PMID: 33290595 DOI: 10.1111/ejn.15077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Imanishi A, Kawazoe T, Hamada Y, Kumagai T, Tsutsui K, Sakai N, Eto K, Noguchi A, Shimizu T, Takahashi T, Han G, Mishima K, Kanbayashi T, Kondo H. Early detection of Niemann-pick disease type C with cataplexy and orexin levels: continuous observation with and without Miglustat. Orphanet J Rare Dis 2020;15:269. [PMID: 32993765 DOI: 10.1186/s13023-020-01531-4] [Reference Citation Analysis]